EVALUATION OF THE ABBOTT SARS-COV-2 IG-G ASSAY
CS Lau, SP Hoo, YL Liang, View ORCID ProfileTC Aw
doi: https://doi.org/10.1101/2020.06.28.20132498
CS Lau
1Department of Laboratory Medicine, Changi General Hospital, Singapore
SP Hoo
1Department of Laboratory Medicine, Changi General Hospital, Singapore
YL Liang
1Department of Laboratory Medicine, Changi General Hospital, Singapore
TC Aw
1Department of Laboratory Medicine, Changi General Hospital, Singapore
2Department of Medicine, National University of Singapore, Singapore
3Academic Pathology Program, Duke-NUS Medical School, Singapore

Article usage
Posted June 30, 2020.
EVALUATION OF THE ABBOTT SARS-COV-2 IG-G ASSAY
CS Lau, SP Hoo, YL Liang, TC Aw
medRxiv 2020.06.28.20132498; doi: https://doi.org/10.1101/2020.06.28.20132498
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)